Alabama SB 225: Pharmacy, State Board of, inspectors renamed investigators, maximum fees increased, frequency of drug supply chain registration increased, further regulation of entities within drug supply chain provided, resale of compound drug products prohibited, Sec. 34-23-32.2 added; Secs. 34-23-152 to 34-23-157, inclusive, repealed; Secs. 20-2-9, 20-2-190, 34-23-1, 34-23-3, 34-23-9, 34-23-30, 34-23-32, 34-23-32.1, 34-23-33, 34-23-70, 34-23-92, 34-23-131, 34-23-159, 34-23-160, 34-23-162 am'd

Status: Pending third reading on day 20 Favorable from Health (as of 2017-04-20)

State: Alabama · Session: 2017rs · Bill: SB 225

Subjects: Pharmacy, Alabama State Board of

Sponsors: Beasley

View Alabama SB 225 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.